These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2942460)
1. Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo. Sprent J; Schaefer M; Lo D; Korngold R Immunol Rev; 1986 Jun; 91():195-218. PubMed ID: 2942460 [TBL] [Abstract][Full Text] [Related]
2. Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens. Sprent J; Schaefer M J Exp Med; 1985 Dec; 162(6):2068-88. PubMed ID: 2933483 [TBL] [Abstract][Full Text] [Related]
3. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens. Mizuochi T; Ono S; Malek TR; Singer A J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862 [TBL] [Abstract][Full Text] [Related]
4. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts. Sprent J; Schaefer M; Gao EK; Korngold R J Exp Med; 1988 Feb; 167(2):556-69. PubMed ID: 2964497 [TBL] [Abstract][Full Text] [Related]
5. Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function. Kruisbeek AM; Mond JJ; Fowlkes BJ; Carmen JA; Bridges S; Longo DL J Exp Med; 1985 May; 161(5):1029-47. PubMed ID: 3921649 [TBL] [Abstract][Full Text] [Related]
6. Frequency analysis of class I MHC-reactive Lyt-2+ and class II MHC-reactive L3T4+ IL 2-secreting T lymphocytes. Heeg K; Steeg C; Schmitt J; Wagner H J Immunol; 1987 Jun; 138(12):4121-7. PubMed ID: 3108383 [TBL] [Abstract][Full Text] [Related]
7. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences. Korngold R; Sprent J J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371 [TBL] [Abstract][Full Text] [Related]
8. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants. Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773 [TBL] [Abstract][Full Text] [Related]
9. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. Via CS; Sharrow SO; Shearer GM J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440 [TBL] [Abstract][Full Text] [Related]
10. Rejection of skin grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells. Woodcock J; Wofsy D; Eriksson E; Scott JH; Seaman WE Transplantation; 1986 Dec; 42(6):636-42. PubMed ID: 2947360 [TBL] [Abstract][Full Text] [Related]
11. A specific serine proteinase is inducible in Lyt-2+,L3T4- and Lyt-2-,L3T4+ T cells in vitro but is mainly associated with Lyt-2+,L3T4- effector cells in vivo. Simon MM; Fruth U; Simon HG; Kramer MD Eur J Immunol; 1986 Dec; 16(12):1559-68. PubMed ID: 3102247 [TBL] [Abstract][Full Text] [Related]
12. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. Rosenberg AS; Mizuochi T; Sharrow SO; Singer A J Exp Med; 1987 May; 165(5):1296-315. PubMed ID: 2437237 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of helper function with anti-Lyt-2 or anti-L3T4 monoclonal antibodies depending on stimulating antigens. Guimezanes A; Schmitt-Verhulst AM Eur J Immunol; 1985 Dec; 15(12):1187-91. PubMed ID: 2935405 [TBL] [Abstract][Full Text] [Related]
14. Role of L3T4 antigen in the activation of various functions of Lyt-1+2- T cells against vaccinia virus. Aoyama A; Yoshioka T; Sato S; Mizushima Y; Ogata M; Ueda S; Kato S; Fujiwara H; Hamaoka T Microbiol Immunol; 1986; 30(8):799-810. PubMed ID: 2946922 [TBL] [Abstract][Full Text] [Related]
15. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma. Chou T; Shu S J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448 [TBL] [Abstract][Full Text] [Related]
16. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts. Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046 [TBL] [Abstract][Full Text] [Related]
17. Capacity of purified Lyt-2+ T cells to mount primary proliferative and cytotoxic responses to Ia- tumour cells. Sprent J; Schaefer M Nature; 1986 Aug 7-13; 322(6079):541-4. PubMed ID: 3090451 [TBL] [Abstract][Full Text] [Related]
18. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. Sprent J; Schaefer M; Lo D; Korngold R J Exp Med; 1986 Apr; 163(4):998-1011. PubMed ID: 3512763 [TBL] [Abstract][Full Text] [Related]
19. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells. Kern DE; Klarnet JP; Cheever MA; Greenberg PD Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of antibodies to Lyt-2 and L3T4 on cytolysis by cloned, Ia-restricted T cells expressing both proteins. Jones B; Khavari PA; Conrad PJ; Janeway CA J Immunol; 1987 Jul; 139(2):380-4. PubMed ID: 3110269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]